INTECH Investment Management
HCAT icon

INTECH Investment Management’s Health Catalyst HCAT Stock Holding History

INTECH Investment Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,559
Closed -$19.8K – 2180
2026
Q1 		$19.8K Sell
15,559
-14,501
-48% -$27.3K ﹤0.01% 2066
2025
Q4 		$71.8K Sell
30,060
-6,738
-18% -$18.4K ﹤0.01% 2218
2025
Q3 		$105K Sell
36,798
-5,212
-12% -$17.8K ﹤0.01% 2245
2025
Q2 		$158K Sell
42,010
-3,575
-8% -$14.1K ﹤0.01% 2169
2025
Q1 		$207K Buy
45,585
+17,199
+61% +$91K ﹤0.01% 2079
2024
Q4 		$201K Buy
28,386
+10,611
+60% +$84.5K ﹤0.01% 2030
2024
Q3 		$145K Buy
+17,775
New +$128K ﹤0.01% 1816

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's HCAT Position: Q2 2026 in Review

INTECH Investment Management sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 15,559 shares — an estimated $19.8K sold.

INTECH Investment Management first reported a position in HCAT in Q3 2024 and held it in 7 quarters. The position peaked at $207K in Q1 2025. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • INTECH Investment Management reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 15,559 Health Catalyst shares in Q2 2026, an estimated $19.8K.
  • INTECH Investment Management first reported a position in Health Catalyst in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's Health Catalyst position peaked at $207K in Q1 2025.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.